Abstract
Immunotherapy has clinical activity in certain virally associated cancers. However, the tumor antigens targeted in successful treatments remain poorly defined.We used a personalized immunogenomic approach to elucidate the global landscape of antitumor T cell responses in complete regression of human papillomavirus-associated metastatic cervical cancer after tumor-infiltrating adoptive Tcell therapy. Remarkably, immunodominant Tcell reactivities were directed againstmutated neoantigens or a cancer germline antigen, rather than canonical viral antigens.Tcells targeting viral tumor antigens did not display preferential in vivo expansion. Both viral and nonviral tumor antigen-specificTcells resided predominantly in the programmed cell death 1 (PD-1)-expressing Tcell compartment, which suggests that PD-1 blockade may unleash diverse antitumor Tcell reactivities.These findings suggest a new paradigm of targeting nonviral antigens in immunotherapy of virally associated cancers.
Original language | English (US) |
---|---|
Pages (from-to) | 200-205 |
Number of pages | 6 |
Journal | Science |
Volume | 356 |
Issue number | 6334 |
DOIs | |
State | Published - Apr 14 2017 |
ASJC Scopus subject areas
- General